Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy

Radiotherapy shows excellent local control in liver cancers but carries the risk of radiation-induced liver dysfunction and liver failure. We conducted a study of plasma hepatocyte growth factor (HGF) in a clinical trial of proton radiotherapy in patients with unresectable liver cancers (NCT00976898...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Theodore S., Grassberger, Clemens, Yeap, Beow Y., Jiang, Wenqing, Wo, Jennifer Y., Goyal, Lipika, Clark, Jeffrey W., Crane, Christopher H., Koay, Eugene J., Dima, Simona, Eyler, Christine E., Popescu, Irinel, DeLaney, Thomas F., Zhu, Andrew X., Duda, Dan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194077/
https://www.ncbi.nlm.nih.gov/pubmed/30374460
http://dx.doi.org/10.1038/s41698-018-0065-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194077/
https://www.ncbi.nlm.nih.gov/pubmed/30374460
http://dx.doi.org/10.1038/s41698-018-0065-y

Ejemplares similares